Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) TB Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on TB Vaccines Industry
  • 1.7 COVID-19 Impact: TB Vaccines Market Trends

    • 2 Global TB Vaccines Quarterly Market Size Analysis

    • 2.1 TB Vaccines Business Impact Assessment - COVID-19
      • 2.1.1 Global TB Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global TB Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global TB Vaccines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global TB Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global TB Vaccines Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers TB Vaccines Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into TB Vaccines Market
    • 3.5 Key Manufacturers TB Vaccines Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on TB Vaccines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Mobile
      • 1.4.2 Benchtop
    • 4.2 By Type, Global TB Vaccines Market Size, 2019-2021
      • 4.2.1 By Type, Global TB Vaccines Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global TB Vaccines Price, 2020-2021

    5 Impact of Covid-19 on TB Vaccines Segments, By Application

    • 5.1 Overview
      • 5.5.1 For Water Analysis
      • 5.5.2 Measuring
      • 5.5.3 Laboratory
      • 5.5.4 Others
    • 5.2 By Application, Global TB Vaccines Market Size, 2019-2021
      • 5.2.1 By Application, Global TB Vaccines Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global TB Vaccines Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Merck & Co.,Inc
      • 7.1.1 Merck & Co.,Inc Business Overview
      • 7.1.2 Merck & Co.,Inc TB Vaccines Quarterly Production and Revenue, 2020
      • 7.1.3 Merck & Co.,Inc TB Vaccines Product Introduction
      • 7.1.4 Merck & Co.,Inc Response to COVID-19 and Related Developments
    • 7.2 Sanofi Pasteur
      • 7.2.1 Sanofi Pasteur Business Overview
      • 7.2.2 Sanofi Pasteur TB Vaccines Quarterly Production and Revenue, 2020
      • 7.2.3 Sanofi Pasteur TB Vaccines Product Introduction
      • 7.2.4 Sanofi Pasteur Response to COVID-19 and Related Developments
    • 7.3 Japan BCG Laboratory
      • 7.3.1 Japan BCG Laboratory Business Overview
      • 7.3.2 Japan BCG Laboratory TB Vaccines Quarterly Production and Revenue, 2020
      • 7.3.3 Japan BCG Laboratory TB Vaccines Product Introduction
      • 7.3.4 Japan BCG Laboratory Response to COVID-19 and Related Developments
    • 7.4 China National Biotec Group
      • 7.4.1 China National Biotec Group Business Overview
      • 7.4.2 China National Biotec Group TB Vaccines Quarterly Production and Revenue, 2020
      • 7.4.3 China National Biotec Group TB Vaccines Product Introduction
      • 7.4.4 China National Biotec Group Response to COVID-19 and Related Developments
    • 7.5 Serum Institute
      • 7.5.1 Serum Institute Business Overview
      • 7.5.2 Serum Institute TB Vaccines Quarterly Production and Revenue, 2020
      • 7.5.3 Serum Institute TB Vaccines Product Introduction
      • 7.5.4 Serum Institute Response to COVID-19 and Related Developments
    • 7.6 India Pvt. Ltd
      • 7.6.1 India Pvt. Ltd Business Overview
      • 7.6.2 India Pvt. Ltd TB Vaccines Quarterly Production and Revenue, 2020
      • 7.6.3 India Pvt. Ltd TB Vaccines Product Introduction
      • 7.6.4 India Pvt. Ltd Response to COVID-19 and Related Developments
    • 7.7 InterVax Ltd
      • 7.7.1 InterVax Ltd Business Overview
      • 7.7.2 InterVax Ltd TB Vaccines Quarterly Production and Revenue, 2020
      • 7.7.3 InterVax Ltd TB Vaccines Product Introduction
      • 7.7.4 InterVax Ltd Response to COVID-19 and Related Developments
    • 7.8 GreenSignal
      • 7.8.1 GreenSignal Business Overview
      • 7.8.2 GreenSignal TB Vaccines Quarterly Production and Revenue, 2020
      • 7.8.3 GreenSignal TB Vaccines Product Introduction
      • 7.8.4 GreenSignal Response to COVID-19 and Related Developments
    • 7.9 Bio Pharma Limited
      • 7.9.1 Bio Pharma Limited Business Overview
      • 7.9.2 Bio Pharma Limited TB Vaccines Quarterly Production and Revenue, 2020
      • 7.9.3 Bio Pharma Limited TB Vaccines Product Introduction
      • 7.9.4 Bio Pharma Limited Response to COVID-19 and Related Developments
    • 7.10 Statens Serum Institut
      • 7.10.1 Statens Serum Institut Business Overview
      • 7.10.2 Statens Serum Institut TB Vaccines Quarterly Production and Revenue, 2020
      • 7.10.3 Statens Serum Institut TB Vaccines Product Introduction
      • 7.10.4 Statens Serum Institut Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 TB Vaccines Supply Chain Analysis
      • 8.1.1 TB Vaccines Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on TB Vaccines Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 TB Vaccines Distribution Channels
      • 8.2.2 Covid-19 Impact on TB Vaccines Distribution Channels
      • 8.2.3 TB Vaccines Distributors
    • 8.3 TB Vaccines Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of TB Vaccines, including the following market information:
      Global TB Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global TB Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global TB Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global TB Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Mobile
      Benchtop

      Based on the Application:
      For Water Analysis
      Measuring
      Laboratory
      Others

      Buy now